How can Monovisc® provide relief from OA knee pain?

Monovisc® is a gel-like substance manufactured from ultra-pure hyaluronic acid and obtained entirely from a non-avian source, supplements the hyaluronic acid naturally found in the synovial fluid of a healthy knee.

Monovisc® is indicated

in the treatment of pain in

OA of the knee

in patients who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics (e.g. acetaminophen).

In clinical trials,

patients who were treated with Monovisc® reported a reduction in pain. Monovisc® was generally well-tolerated; no serious adverse events were reported.

Monovisc® is administered

by your doctor as a single intra-articular injection, a treatment called viscosupplementation. Viscosupplements are thought to relieve OA pain by restoring the viscoelastic properties of the hyaluronic acid found in the knee.

You can learn more about Monovisc® by reading our brochure on OA knee pain and treatment.

What type of doctor usually treats patients with Monovisc®?

  • Orthopedist: a physician specializing in the skeletal system and its associated joints and ligaments.
  • Sports medicine specialist: a physician specializing in injuries from athletic activities.
  • Rheumatologist: a physician specializing in rheumatic disorders.


Orthovisc® is a viscosupplement option indicated for the symptomatic treatment of osteoarthritis (OA) of the knee. It is administered as three weekly, intra-articular injections over the course of three vials. It lubricates, cushions and protects the knee joint, providing pain reduction for up to 6 months.